数据
资源
版本对比
免费注册
预约演示
免费注册
Vetter
Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards
2024-03-26
·
BioSpace
Trusted Industry Recognition Reinforces
Vetter
's Commitment to Excellence Recognized as a leading partner for all kinds of pharma and biotech enterprises Award reaffirms mission to provide the highest possible quality and value for customers and their patients 2023 sales result showcases the company's continuous sustainable growth Ravensburg, Germany, March 26, 2024:
Vetter
once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents. The award reaffirms
Vetter
’s mission to provide the highest possible quality and value for pharma and biotech companies worldwide in their development, manufacturing as well as assembly and packaging of injectables. “We are dedicated to embodying the characteristics that this award highlights to provide the best to our customers and their patients. We leverage our decades of experience and the expertise of our 6,300 employees to do so,” shared
Vetter
’s Managing Director Peter Soelkner. “To be recognized once again by the CDMO Leadership Awards is a testament that we are living out our company mission in the work we do every day.” In fact, with a result of € 1,002 million in completed orders over the past financial year,
Vetter
has successfully reached to surpass the one billion sales threshold. This confirms the strong commitment to stable customer relationships and ongoing sustainable growth. The awards program provides a unique representation of the level of excellence offered to customers, as honorees are selected based on customer evaluations of the CDMOs they have worked with over the past 18 months. Now in its 13th year,
Outsourced Pharma
and Life Science Leader's CDMO Leadership Awards provide its audiences with accurate and dependable customer feedback to help them select a reputable partner for their development, manufacturing and packaging needs. “As drug owners are increasingly counting on CDMOs to provide unwavering access to supply chains, appropriate infrastructure, and proven processes, the CDMO Leadership Awards reflect our commitment to act as their outsourcing partner of choice, said
Vetter
Managing Director Thomas Otto. “We are proud that this further instills a sense of confidence in our trustworthiness among our current and future customers.” Louis Garguilo, Chief Editor and Conference Chair of
Outsourced Pharma
added: “Drug and therapy sponsors had much to be concerned with during the last 12 months or so. There was still supply-chain uncertainty, ever-growing novelty in platforms and processes requiring new skill sets and technologies, and the speed of everything seemed to accelerate. Through it all, CDMOs stayed focused and also adapted to customer and market needs. Those best at serving their customers and thus patients are recognized as the 2024 CDMO Leadership Award winners.” ©
Vetter Pharma International
: The
Vetter
team including Managing Director Peter Soelkner (2nd from left) is proud to accept the CDMO Leadership Awards 2024 on behalf of the company. Find the
Vetter
press kit and more background information here. About
Vetter
Vetter
is a leading Contract Development and Manufacturing Organization (CDMO) with headquarters in Ravensburg, Germany, and production facilities in Germany, Austria, and the US. As a global player, the pharmaceutical service provider is also present with its own sales locations in the Asia-Pacific markets of Japan, China, South Korea and Singapore. Around the world, small and large renowned pharma and biotech companies rely on the decades of experience, high quality, modern technologies, reliability, and commitment of more than 6,300 employees. In close partnership with its customers, the
Vetter
team supplies patients all over the world with medicines, many of which are vital. The CDMO provides support from drug product development through clinical and commercial filling to a wide range of assembly and packaging services for vials, syringes, and cartridges. With innovative solutions,
Vetter
develops prefilled drug-delivery systems together with its customers to continuously improve patient safety, comfort, and compliance. The company is an industry pioneer in sustainability and a socially and ethically responsible corporate citizen. The CDMO is a member of the UN Global Compact and Science Based Target initiative (SBTi) and received platinum status in the renowned EcoVadis ranking. Multiple awards such as the CDMO Leadership Awards, Frost & Sullivan Customer Value Leadership award or the recognition as Best Managed Company emphasize
Vetter
’s commitment to sustainable business. Founded in Ravensburg in 1950, the company remains family-owned to this day. For more information, visit and follow
Vetter
on LinkedIn. Contact Vetter Pharma International GmbH Markus Kirchner Corporate Spokesperson / Media Relations Eywiesenstrasse 5 88212 Ravensburg Germany Phone: +49 (0)751-3700-3729 E-mail: PRnews@vetter-pharma.com
更多内容,
请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
机构
Vetter Pharma-Fertigung GmbH & Co. KG
Outsourced Pharma
Vetter Pharma International USA, Inc.
适应症
-
靶点
-
药物
-
标准版
¥
16800
元/账号/年
新药情报库 | 省钱又好用!
立即使用
热门报告
第一三共ADC药物DS-8201专利调研实务指南
智慧芽生物医药
2024年3月全球首批及特殊审评药物报告
智慧芽生物医药
THR-β 激动剂药物进展及专利调研报告
智慧芽生物医药
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
开始免费试用
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。
试用数据服务